A protein, called inositol-requiring enzyme 1 – IRE1 – may serve as a key driver in a series of molecular interactions that can both promote and, paradoxically, inhibit tumors in certain types of cancers, such as non-melanoma skin cancers, according to a team of molecular biologists. They add that this pathway’s dual power may make it a tempting target for future research on the design of new types of anti-cancer therapeutics.
from Top Health News – ScienceDaily http://ift.tt/2wQ2rxW
from Tumblr http://ift.tt/2voY2C5
No comments:
Post a Comment